Aerobic Exercise as a Countermeasure for Night Shift Associated Circadian Misalignment
SHIFT-EX
The Impact of Exercise on Cardiometabolic Health During Shiftwork: A Proof of Concept Study
1 other identifier
interventional
16
1 country
1
Brief Summary
This study plans to learn more about whether exercise can help protect the body from health problems that happen when a person's sleep and daily schedule are out of sync with their natural body clock (circadian rhythm).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy
Started Jul 2026
Typical duration for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 19, 2026
CompletedFirst Posted
Study publicly available on registry
June 25, 2026
CompletedStudy Start
First participant enrolled
July 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2028
June 25, 2026
June 1, 2026
1.4 years
June 19, 2026
June 19, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
24-hour ambulatory BP
: During your WRIC visits on day 2 and day 5, a blood pressure cuff will be placed on your non-dominant arm to measure blood pressure every 30 minutes during the day and every 60 minutes at night.
Days 2 and 5
Mixed Meal Tolerance Test
On days 2 and 5, approximately 1 hour after waking up, you will have your blood drawn via an IV in your arm and will be given a liquid shake to consume. Over the course of 2 hours, regular, frequent blood samples will be collected through the IV over the duration of this test.
Days 2 and 5
Study Arms (2)
Control
NO INTERVENTIONParticipants in this arm will engage in simulated daytime work, with nighttime sleep, followed by 3 days of simulated night shift work, with day time sleep.
Exercise
EXPERIMENTALParticipants in this arm will engage in simulated daytime work, with nighttime sleep, followed by 3 days of simulated night shift work, with day time sleep. In addition, participants will engage in a 45-minute bout of moderate intensity exercise at 2.5 hours after waking on days 3, 4, and 5.
Interventions
Participants will engage in a 5-day stay that includes simulated daytime work, with nighttime sleep, followed by 3 days of simulated night shift work, with daytime sleep. On days 1, 3, and 4, participants will be provided food to eat (Day 1 +/- 1 hour:\~18:00 and \~23:00, Day 3 +/- 1 hour: \~08:30, \~13:00, \~18:00, \~23:00, and \~04:00. Day 4 +/-1 hour: \~18:00, \~23:00, \~04:00, and \~07:00). On days 2 and 5, participants will be provided with a diet to maintain your current weight (30% breakfast, 30% lunch, 30% dinner, 10% snack). On Day 2, participants will be provided a diet to be consumed at the following times: breakfast 08:30, lunch 13:00, dinner 18:00, snack 23:00. On Day 5, participants will follow a night shift schedule and meal timing that will follow the following schedule: breakfast 18:00, lunch 23:00, dinner 04:00, snack 07:00. Participants will engage in a 45-minute bout of moderate intensity aerobic exercise at 2.5 h after waking on days 3, 4, and 5.
Eligibility Criteria
You may qualify if:
- Age 18-40 years
- Body Mass Index 18.5-\<40kg/m\^2
- Physically inactive: defined as \<150 minutes per week of voluntary exercise at moderate intensity or greater and \<60 min per day of total habitual physical activity (i.e., work related, transportation related) at moderate intensity or greater, over the past 3 months.
- No plans to relocate within the next 6 months.
- No plans for extended travel (\>2 weeks) within the next 3 months.
You may not qualify if:
- Have a primary care physician (or are willing to establish care with a primary care physician prior to study enrollment) to address medical issues which may arise during screening or study procedures.
- No contraindications to exercise or limitations on ability to be physically active.
- Ability to adhere to sleeping, eating, and exercise protocol
- Willing and able to wear activity/sleep monitor for 7 consecutive days.
- For Females:
- Not currently pregnant or lactating.
- Not pregnant within the past 6 months.
- Not planning to become pregnant in the next 6 months
- Regularly timed menstrual cycles to facilitate measurement of EE in the early follicular phase.
- Diastolic blood pressure \>100 mmHG, systolic blood pressure \>160 mmHG, or resting heart rate \>100 bpm as measured in duplicate on the screening visit after 5 minutes of rest in a seated position.
- Diabetes (fasting glucose \>/=126 mg/dL or Hemoglobin A1C \>/=6.5%) as measured during the screening visit.
- Undiagnosed hypo- or hyper-thyroidism (TSH outside of the normal range as measured during the screening visit) or history of uncontrolled thyroid disorder. History of thyroid disease or current thyroid disease treated with a stable medication regimen for at least 6 months is acceptable.
- Triglycerides \>400 mg/dL as measured on the screening visit.
- LDL cholesterol \>200 mg/dL as measured on the screening visit.
- Abnormal resting electrocardiogram (ECG) as measured on the screening visit: serious arrhythmias, including multifocal PVC's, frequent PVC's (defined as 10 or more per min), ventricular tachycardia (defined as runs of 3 or more successive PVC's), or sustained atrial tachyarrhythmia; 2nd or 3rd degree A-V block, QTc interval \> 480 msec or other significant conduction defects.
- +20 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Colorado Anschutz Medical Campus
Aurora, Colorado, 80045, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Seth Creasy, PhD
University of Colorado, Denver
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 19, 2026
First Posted
June 25, 2026
Study Start
July 1, 2026
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
July 1, 2028
Last Updated
June 25, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share